Category Archives: human granulocytic anaplasmosis

Researchers near development of a vaccine against tick-transmitted disease.

Virginia Commonwealth University researchers have made an important advancement toward developing a vaccine against the debilitating and potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA). During the past several years, experts have seen a steady rise in the incidence of human infections caused by tick-transmitted bacterial pathogens, making the need for a vaccine critical. Successful vaccine development hinges on knowing

Read more